Author

Yu-Wei Chen

Institutions: University of California San Diego, Moores Cancer Center

Observed institutions: University of California San Diego, Moores Cancer Center

ORCID: 0000-0001-7988-319X

Observed ORCID: 0000-0001-7988-319X

OpenAlex ID: A5126887140

Genomic and clinical correlates of belzutifan treatment in renal cell carcinoma (RCC): A retrospective analysis of 240 RCC patients.

2026 · Yu-Wei Chen, Shayan S. Nazari, et al. · Journal of Clinical Oncology · 1

Comprehensive characterization of HIF-2α and carbonic anhydrase IX expression and the genomic landscape in clear cell and VHL -altered renal cell carcinoma.

2026 · Yu-Wei Chen, Shayan S. Nazari, et al. · Journal of Clinical Oncology

Genomic and clinical correlates of belzutifan treatment in renal cell carcinoma (RCC): A retrospective analysis of 150 RCC patients.

2026 · Harshitha Reddy Dudipala, Yu-Wei Chen, et al. · Journal of Clinical Oncology

A phase 2 study of cabozantinib and nivolumab in metastatic castration resistant prostate cancer (CANOPY): Interim analysis.

2026 · Justine Ann Panian, Lin Liu, et al. · Journal of Clinical Oncology

Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102).

2026 · Yu-Wei Chen, Olivia Bobek, et al. · Journal of Clinical Oncology

Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer

2026 · Yu-Wei Chen, Joanne Xiu, et al. · JCO Precision Oncology

Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-resistant Prostate Cancer

2026 · Chinmay T. Jani, Eli Tran, et al. · Clinical Cancer Research

Works count: 7

Citation count: 1

H-index: 1

I10-index: